The demands of bringing novel therapy facilities online can be pressure-filled, with high stakes for the companies, and the engineers and designers tasked with ensuring success. Working side-by-side with novel drug companies, experienced engineers can identify and overcome hurdles that arise when facing the transfer from research to production scale. Since novel drug companies’ familiarity with facilities for pharmaceutical manufacturing can range from expert to novice, everyone involved has to be in the trenches together. “Notes from the Trenches: Lessons Learned in Engineering Novel Drug Therapy Facilities” by DPS Group’s Jeff Lewis, Ryan McDonough, and Eddie Skillington. featured in Labcompare takes a high-level look at some of the challenges and lessons learned in designing novel therapy facilities – and what to keep in mind when working with engineers and designers to create these new facilities.